We are pleased to announce the commercialization of “N-NOSE plus Pancreas”, the world’s first cancer type specific test, the next generation of the N-NOSE nematode cancer test.
“N-NOSE plus Pancreas”, the world’s first test to detect early-stage pancreatic cancer, is now available for practical use.
We will start airing a new TV commercial for "N-NOSE plus Pancreas". Our goal is to increase awareness of this test as a means of detecting pan . . .2022.11.17
Hirotsu Bio Science INC. has joined the Global Innovators Community of World Economic Forum since November 1 of this year. This community brings . . .2022.11.14
We are pleased to announce that our N-NOSE has been introduced as part of Sojitz Corporation's efforts to maintain and promote health for its em . . .2022.11.11